Small-molecule active pharmaceutical ingredients of approved cancer therapeutics inhibit human aspartate/asparagine-ß-hydroxylase. (2020)

First Author: Brewitz L
Attributed to:  RapidFire Enhancement of Mass Spectrometry Capability Across the Biosciences funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.bmc.2020.115675

PubMed Identifier: 33069066

Publication URI: http://europepmc.org/abstract/MED/33069066

Type: Journal Article/Review

Volume: 28

Parent Publication: Bioorganic & medicinal chemistry

Issue: 20

ISSN: 0968-0896